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PURPOSE. Mutations in the gene encoding Gasdermin A3 (Gsdma3) have been described to
cause severe skin phenotypes, including loss of sebaceous glands and alopecia, in mice. We
discovered a novel C-terminal mutation in Gsdma3 in a new mouse line and characterized a
less frequently reported corneal phenotype, likely caused by degeneration of Meibomian
glands of the inner eyelid.
METHODS. We used histologic methods to evaluate the effects of the Cþ/H mutation on
sebaceous gland and skin morphology as well as Meibomian glands of the inner eyelid and
corneal tissue. Chromosomal aberrations were excluded by karyogram analyses. The mutation
was identified by Sanger sequencing of candidate genes.
RESULTS. Analyses of skin samples from affected mice confirmed the frequently reported
phenotypes associated with mutations in Gsdma3: Degeneration of sebaceous glands and
complete loss of pelage. Immunologic staining of corneal samples suggested an inflammatory
response with signs of neovascularization in half of the affected older mice. While the corneal
phenotype was observed at irregular time points, mainly after 6 months, its appearance
coincided with a degeneration of Meibomian glands in the eyelids of affected animals.
CONCLUSIONS. The mutation described herein is associated with inflammation and neovascu-
larization of corneal tissue. Simultaneous degeneration of Meibomian glands in affected
animals suggested a change in tear-film composition as the underlying cause for the corneal
phenotype. Our data further support that different pathogenic mechanisms underlie some of
the reported mutations in Gsdma3.
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Mutations in the C-terminal region of Gsdma3, the geneencoding the Gasdermin A3 protein in mice, lead to a
phenotype characterized by complete hair-loss, hyperkeratini-
zation of the skin, and degeneration of sebaceous glands in
adult mice. Holocrine gland degeneration occasionally affects
the Meibomian glands of the inner eyelid, leading to
inflammation of the corneal epithelium and excessive prolifer-
ation of corneal tissue in older animals.1–3
Hair-loss is described in detail and is a phenotype observed
in all 11 known Gsdma3 mutant mouse lines (Alopecia [Ae],4
Bareskin [Bsk],5 Defolliculated [Dfl],2 Finnegan [Fgn],6 Michel-
in [M1Btlr], Mr. Magoo [M2Btlr], I359N [Mhdaclp1],7 Reduced
coat 2 [Rco2],8 Rex-denuded [Re-Den],9 recombination-induced
mutation 3 [Rim3]1 and RIKEN00745/þ3). Only a selection of
publications described morphologic changes in the eyelid and
cornea in detail.1,2,8,10
The phenotype of the corneal epithelium is likely a
secondary effect of disrupted sebum secretion of defective
Meibomian glands of the inner eyelid, leading to rapid
evaporation of the tear-film that protects the cornea from
drying-out.2 Interestingly, Meibomian gland dysfunction is also
associated with evaporative dry eye (EDE) disease, which is one
of the most prevalent diseases of the human eye.11–13
The tear-film consists of a mucin, an aqueous and a lipid
layer in varying ratios. Changes in its composition alter its
protective and refractive properties.13 Meibomian glands
provide the outermost lipid layer of the tear-film, thereby
preventing premature evaporation of tears and drying of the
cornea.14 This is achieved by secretion of lipid-filled lobular
cells, which constantly regenerate from nearby progenitor
cells.15
In the disease EDE, Meibomian glands show dysfunctional
secretion of sebum. In the majority of cases, this is caused by an
obstruction of their ductal system by cell debris or solidified
sebum which, if untreated, can lead to further degeneration of
the glands.11,13 Phenotypically, EDE can manifest in an
inflammation of corneal tissue or the eyelid itself and impairs
the regeneration of corneal tissue after injury.11 Treatment for
the obstructive form of EDE consists of massages of the eyelid
to loosen blockage of the Meibomian gland ducts and the
application of artificial tears to rehydrate the eyes.11 Since
complete degeneration of Meibomian glands can be observed
in untreated EDE cases, Gsdma3 mutant mice that show a
degeneration of Meibomian glands have the potential to serve
as a disease model to understand the pathogenic processes of
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the corneal alterations and the development of treatment
options for the late stage of EDE.
Interestingly, the corneal phenotype is not described in all
known Gsdma3 mutants and for two of these mouse lines
(Rco2 and RIKEN00745/þ) even functional Meibomian glands
have been observed, despite the absence of sebaceous glands
in the skin of these animals.3,8
Gsdma3 is located on chromosome 11 in mice and encodes
for the 464 amino acid protein Gasdermin A3, which is part of
the Gasdermin family of proteins.16 Saeki et al.16 have found
Gasdermin A3 to be primarily expressed in skin and stomach
using Northern blot analysis, while Runkel et al.8 detected
Gsdma3 mRNA in progenitor cells of Meibomian glands
employing in situ hybridization. The protein is believed to
play a role in the murine hair follicle cycle,6,17,18 mammary
gland development,19 and mitochondrial homeostasis.20 It
displays a two-domain structure comprising a 35-kDa N-
terminal and a 25-kDA C-terminal domain connected by an
intermediate region.21 While the majority of a total of 14 b-
sheets are located in the N-terminal domain, most of the 12 a-
helices are located in the globular C-terminal domain.21
In wild type, the C-terminal domain of Gasdermin A3
autoinhibits its N-terminal domain via interactions between
helices a12 and a1, as well as helices a4, a9, and a11.21 Upon
cleavage of the protein at the intermediate region by an
unknown activator, the C-terminal domain dissociates from the
N-terminus, leading to its activation. All known Gsdma3
mutations disrupt this autoinhibitory function of the C-
terminus leading to constant activation of the N-terminal
domain.22 Activated N-terminal domains form pore-like multi-
mers that incorporate into the cell membrane leading to
pyroptotic cell death of lipid-filled gland cells.21
In this study, we describe a novel mutation (Cþ/H: cornea
plus, hair minus) in the far C-terminal region of Gasdermin A3
that causes both skin and corneal phenotypes. This mouse
model develops its corneal phenotype likely due to Meibomian
gland deficiency and might serve as a disease model for late
stage EDE.
MATERIALS AND METHODS
Mice
The novel mutation described herein arose spontaneously in a
BL6/J line that carries a homozygous mutation in the gene
encoding membrane- type fr izz led-re la ted protein
(MFRPrd6/rd6). Affected mice were discovered by their obvious
hairless appearance and backcrossed to MFRPwt/wt BL6/J.
Mice were anesthetized and killed by cervical dislocation at
different time points (postnatal days 7 and 28 [P7 & P28], 2
months [M], 3M, 4M, 6M, and older) to prepare skin and
cornea, as well as eyelid samples for further analysis.
All animal experiments adhere to the ARVO Statement for
the Use of Animals in Ophthalmic and Vision Research and
were approved by the Niedersa¨chsisches Landesamt fu¨r
Verbraucherschutz und Lebensmittelsicherheit (LAVES, refer-
ence number 14-1671).
Analysis of Skin and Cornea Morphology
Skin samples were prepared from five different body regions:
cranial, dorsal-cranial, dorsal, ventral, and axillary and fixed in
Roti Histofix 4% (Carl Roth, Karlsruhe, Germany) for several
days. The fixed tissue was embedded in paraffin (Carl Roth)
and cut to 4- to 7-lm slices on a Jung HN40 sliding microtome
(Leica Biosystems, Nussloch, Germany). Whole eyes were
prepared in the same manner for analysis of corneal
morphology. Upper eyelids from affected animals and wild
type littermates were fixed for 2 hours in 4% paraformalde-
hyde (Carl Roth), embedded in TissueTek OCT compound
4583 (Sakura Finetek GmbH, Staufen, Germany), and cut to
20-lm slices on a Leica CM1860 cryotome (Leica, Wetzlar,
Germany).
Histologic staining of skin and cornea samples was
performed using the hematoxylin-eosin (HE) method. Slices
were deparaffinized by incubation in xylol (3 minutes; Carl
Roth) followed by ethanol (100%, 95%, 70%, 1 minute each;
Carl Roth) and stained with Mayers hematoxylin (1 minute; Fa.
Walter, Kiel, Germany) and eosin (2.5 minutes; Merck,
Darmstadt, Germany) solutions. For dehydration, slices were
incubated in 70% ethanol for 70 seconds followed by 95%,
100% ethanol and xylol for 100 seconds each and embedded in
Roti Histokitt II medium (Carl Roth). All steps were performed
at room temperature (RT).
Eyelids were stained with HE according to the following
protocol: 2-minute wash with ddH2O, 30-second staining with
Mayers hematoxylin (Carl Roth), 15-minute rinse with tap
water, 30-second counter staining with eosin G solution (Carl
Roth), and dehydration with 70%, 95%, and 100% ethanol and
xylol (2 minutes each). After dehydration, slices were
embedded in Roti Histokitt II medium (Carl Roth). All steps
were performed at RT.
Sudan III staining was performed by 2-minute wash with
ddH2O, 10-minute incubation in Sudan III solution (3% Sudan
III dissolved in 10% ethanol/90% acidic acid; Carl Roth), 2-
minute differentiation in 50% ethanol, and a final 2-minute
wash with ddH2O at RT.
Slices were embedded in Roti Histokitt II medium (Carl
Roth) and scanned on a Zeiss Axio Scope A1 (Carl Zeiss, Jena,
Germany) at magnifications of 503 and 2003 using Zeiss ZEN
Software version 2.3.
Antibody staining of corneas and eyelids was carried out
employing the following protocol: 3 times 5-minute wash with
0.1 M phosphate buffer (PB; pH 7.4; Carl Roth), 60-minute
incubation in blocking solution at RT (0.1 M PB with 3% bovine
serum albumin and 0.5% Triton X-100; Carl Roth), incubation
with primary antibody over night at 48C, 3 times 5-minute
wash with PB at RT, 120-minute incubation with secondary
antibody (in blocking solution), and three final washing steps
with PB (5 minutes each) at RT. Slices were embedded in Dako
Fluorescent Mounting Medium (Carl Roth) and scanned on a
Leica DMRE confocal microscope with a TCS laser unit (Leica)
using Zeiss 403 and 633 oil-immersion objectives (Carl Zeiss).
Images were processed with FIJI version 1.49 (http://fiji.sc, in
the public domain).
The following antibodies were used: rabbit anti-Laminin
(Novus Biological, Abington, UK; NB300-144, 1:500), rat anti-
mCD3 (R&D Systems, Minneapolis, MN, USA; MAB4841, clone
17A2, 1:500), donkey anti-rabbit Alexa 488 conjugated (Life
Technologies, Carlsbad, CA, USA; 1:1000), donkey anti-rabbit
Alexa 647 conjugated (Life Technologies; 1:1000), and goat
anti-rat Alexa 488 conjugated (Invitrogen, Carlsbad, CA, USA;
1:1000).
The number of mice analyzed in the different disease stages
were: P7–P28 (onset of skin phenotype): n ¼ 11; 2M–5M
(development of skin phenotype): n¼ 22; 6M–10M (onset and
development of corneal phenotype): n ¼ 14; 11M–17M (late
stages of corneal phenotype): n¼ 29.
Macroscopic Analysis of Corneal Tissue
Macroscopic imaging of mouse eyes was carried out on an
Olympus SZ51 binocular with an Olympus KL300 LED light
(Olympus Deutschland GmbH, Hamburg, Germany).
Novel C-Terminal Mutation in Gsdma3 IOVS j January 2018 j Vol. 59 j No. 1 j 562
Downloaded From: https://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/936670/ on 11/26/2018
Metaphase Chromosomes Preparations
Chromosomes were obtained from lymphocyte cultures accord-
ing to Arakaki and Sparkes23 methods. The 1 mL Na-heparin
stabilized peripheral blood was cultivated for 72 hours in the
culture medium containing 10 mL RPMI-1640 (Sigma-Aldrich
Corp., St. Gallen, Switzerland) with 1.5 mL FCS, mitogen
Pokeweed 0.35 mL (Sigma-Aldrich Corp.), Amphotericin 0.1 mL
(Sigma-Aldrich Corp.) and penicillin þ streptavidin 0.1 mL
(Roche, Basel, Switzerland). The lymphocytes were treated with
Colcemid (0.5 mL for each 10 mL of culture medium) for 2
hours (KaryoMAX Colcemid Solution in PBS; Gibco, Darmstadt,
Germany, category number: 15212012, concentration 10 lg/
mL). After centrifugation (800 rpm, 8 minutes, þ248C) and
removal of the supernatant, a hypotonic KCl solution (0.075 M,
þ378C) was added drop-wise up to 12 mL. Then cells were
incubated for 20 to 25 minutes atþ378C. After this incubation,
further centrifugation and removal of supernatant, cells were
fixated by slowly dropping the frozen (308C) Carnoy’s fixative
(absolute methanol and glacial acetic acid in proportion 3:1) up
to 15 mL. The samples were centrifuged (800 rpm, 8 minutes,
þ48C) and the supernatant was discarded. The Carnoy’s fixative
was newly added up to 10 mL.
The concentrated chromosome suspension was finally
dropped onto cold, humid microscope slides (10 lL per slide)
and incubated at þ378C for 24 hours.
Multicolor Fluorescence In Situ Hybridization
(mFISH)
mFISH was performed according to the MetaSystem protocol for
Mouse Multicolor FISH Probes (MetaSystems Probes GmbH,
Altlussheim, Germany, category number D-0425-120-DI). An
Axio Imager Z1 microscope (Carl Zeiss AG, Feldbach, Switzer-
land) with a fluorescent 100-watt mercury lamp (HBO), filter set
and ISIS imaging system for mFISH was used for microscopic
analyses. In total, 50 metaphases were captured and analyzed.
For each animal, three karyograms were performed.
DNA Extraction and PCR Amplification of Gsdma3
DNA was extracted from tail biopsies taken at P14. Tail biopsies
were incubated in 600 lL TNES2 buffer (100 mM Tris pH 8.0,
200 mM NaCl, 5 mM EDTA, 0.2% SDS [Carl Roth] and 100 mg/
mL Proteinase K [New England Biolabs, Frankfurt a.M.,
Germany]) at 558C overnight while shaking at 1000 rpm.
Lysed tail biopsies were centrifuged at 10,000g for 5 minutes
the next day. Supernatant was diluted 1:100 with ddH2O and
used for PCR amplification of Gsdma3 and Sanger sequencing.
Amplification of Gsdma3 exons and flanking intronic regions
was carried out using intronic primers (see Supplementary
Data) with the following PCR protocol on a Bio-Rad T100
Thermal Cycler (Bio-Rad Laboratories GmbH, Munich, Ger-
many): initial denaturation: 15:00 at 958C; (denaturation: 0:45
at 958C, annealing: 0:45 at 608C, elongation: 0:30 at 728C)335;
final elongation: 10:00 at 728C; hold at 108C.
Sanger Sequencing of Gsdma3 Gene
All 11 exons and flanking intronic regions of Gsdma3 were
sequenced using intronic primers (see Supplementary Data).
Sequencing was performed on ABI Prism 3130xl Genetic
Analyzer (Applied Biosystems, Carlsbad, CA, USA) according to
Sanger’s protocol24 using BigDye Terminator version 3.1
(ThermoFisher Scientific, Darmstadt, Germany) and the
following cycle-sequencing protocol: initial denaturation:
1:00 at 968C; (denaturation: 0:10 at 968C, annealing: 0:05 at
508C, elongation: 1:15 at 608C) 315; (denaturation: 0:10 at
968C, annealing: 0:05 at 508C, elongation: 1:30 at 608C) 35;
(denaturation: 0:10 at 968C, annealing: 0:05 at 508C, elonga-
tion: 2:00 at 608C) 310; hold at 108C.
Based on the phenotype and genotype results, the pedigree
of the first four generations of the Cþ/H mouse line was
generated (CeGaT Online tool, in the public domain, http://
www.cegat.de/fuer-aerzte/stammbaumerstellung).
3D Modeling of Gasdermin A3 and SIFT Prediction
A 3D model of Gsdma321 was obtained from the Protein Data
Bank in Europe (in the public domain, https://www.ebi.ac.uk/
pdbe/entry/pdb/5B5R) and modified using JMol version
14.10.0 (in the public domain, http://jmol.sourceforge.net/).
Impact of amino acid changes in the primary structure of
Gasdermin A3 was evaluated using SIFT scoring25 at http://sift.
jcvi.org (in the public domain), using the amino acid sequence
of wild-type Gasdermin A3 as reference.
RESULTS
The Cþ/HMouse Is Affected by a Gsdma3
Mutation Showing an Autosomal-Dominant Mode
of Inheritance
Analysis of a four-generation pedigree (Fig. 1A) suggested an
autosomal-dominant mode of inheritance as both sexes were
equally affected and the percentage of affected offspring was
approximately 50% in every generation.
The karyograms of affected animals showed no obvious
differences to unaffected littermates (Fig. 1B). We found no
indication of chromosomal aberrations, neither balanced or
unbalanced. Furthermore, trisomic karyograms were not
detected. This suggested that chromosomal aberrations are
not the cause of the dominant inheritance leading to the Cþ/
H phenotype.
The phenotypic similarities between Cþ/H and previously
described mouse models suggested Gsdma3 as a candidate
gene. Sanger sequencing of the coding exons and flanking
intronic regions revealed a 1-bp insertion in exon 11 of
Gsdma3 (c.1280_1281insC, Fig. 1C) resulting in a frame shift
(p.Gln427Profs*30) in the amino acid sequence and a
premature stop codon at position 457.
Cþ/HMice Displayed Progressive Hair-Loss and
Degeneration of Sebaceous Glands in the Skin
Affected animals were distinguishable from wild-type litter-
mates by the appearance of skin folds at the neck at
approximately P7 and an irregular first coat. Hair-loss started
at approximately P21 at the snout and progressed caudally (see
Supplementary Data, Figs. S1A, S1B).
A thinner second coat emerged at approximately P33
starting at the head of the animal that continued to grow
toward the tail of the animal. Shortly after its appearance, the
second coat was lost. Loss of the second coat showed a head-
to-tail progression similar as observed with the first coat.
Except eyelashes and vibrissae, the animals appeared furless at
approximately 3 to 4 months of age (see Supplementary Data,
Figs. S1C–S1F).
Morphologically, the skin of affected animals showed
thickening of the epidermal layer as early as P7 (Figs. 2A, 2B)
and progressive degeneration of sebaceous glands started at
approximately P28 (Figs. 2C, 2D). Hair-follicles were still
present at P28 and 2 months (Figs. 2E, 2F). At approximately 3
to 4 months of age, hair-follicles and sebaceous glands were
absent from the skin of affected animals (Figs. 2G–J).
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Macroscopically, the skin of affected animals appeared brittle
with a grayish color.
Half of Cþ/HMice Developed Corneal Opacities
and Showed Inflammation of Corneal Tissue
Approximately half of Cþ/H animals older than 6 months
showed corneal opacities (Fig. 3A) that developed into a
macroscopic increase of corneal tissue over time (Fig. 3B). In
addition to these macroscopic alterations of the cornea, blood
vessels seemed to have infiltrated the tissue and closure of the
eyelid was impaired (Figs. 3C, 3D).
Out of a total of 186 heterozygotes, 104 animals (55.9%)
developed a corneal phenotype with 38 animals unilaterally
(20.4%) and 66 animals bilaterally (35.5%) affected. Only 10
FIGURE 1. Genetic analyses of the Cþ/H genotype. (A) The pedigree of the first four generations of the Cþ/Hmouse line revealed a homogenous
distribution of affected and unaffected animals across both sexes and showed affected mice in every generation, highly suggestive of an autosomal
dominant inheritance pattern. (B) Karyograms of an unaffected mouse (upper panel) and its affected littermate (lower panel) showed no obvious
numerical or structural aberrations of the chromosomes. (C) Sanger sequencing of the candidate gene Gsdma3 (upper panel: wild type sequence;
lower panel: heterozygously mutated sequence) revealed an insertion of a single cystine base (arrow) in exon 11 of Gsdma3 (c.1280_1281insC),
which was predicted to lead to an amino acid exchange and a frame shift starting at Glutamine 427. The frame shift was predicted to result in a
premature stop codon at position 457 (p.Gln427Profs*30).
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animals out of the 104 developed a corneal phenotype prior to
the age of 6 months (9.6%).
In the first 3 months of life, histologic analysis of Cþ/H
corneas revealed no apparent morphologic differences be-
tween affected animals and their wild-type littermates (Figs.
4A–I). Neovascularization seemed to occur in corneas of some
affected animals as early as 4 months of age (Fig. 4J).
An aberrant increase in size of the stromal layer (Figs. 5C,
5D, 5G, 5H, 5K, 5L) and possible signs of neovascularization
(Fig. 5, asterisks) could be observed in approximately half of all
Cþ/H animals from 6 months onwards, while corneas of their
wild-type littermates showed normal morphology (Figs. 5A, 5B,
5E, 5F, 5I, 5J).
Antibody staining with anti-Laminin suggested angiogenesis
of blood vessels in the stromal layer of the cornea (Figs. 6K, 6L,
6W, 6X, 6AA, 6AB). These vessels seemed to grow toward the
epithelial layer (Figs. 6AA, 6AB, asterisks) and were morpho-
logically observed in this layer at later stages (Fig. 5, asterisks).
The central part of the cornea showed the most pronounced
macroscopic increase. Infiltrating CD3þ T-cells are also present
in this area (Figs. 6J, 6V, 6Z). Furthermore, the Descemet’s
membrane of the cornea appears compromised in Cþ/Hmice
as shown by irregular or weakened laminin signals in animals
that exhibit a clear corneal phenotype (Fig. 6, arrows).
Epithelial blood vessels were present in wild-type (Figs. 6A–
D, 6M–P, arrowheads) and unaffected Cþ/Hmice (Figs. 6E–H,
6Q–T, arrowheads) but undetectable in the epithelium of mice
displaying a clear corneal phenotype (Figs. 6I–L, 6U–AB,
arrowheads).
In older affected mice, the epithelial layer was also
thickened (Figs. 5G, 5H, 5K, 5L, double crosses) and presented
possible blood (asterisks) and lymphatic vessels (pluses). The
corneal increase appeared to continue growing in size
throughout the lifespan of the animal (Figs. 5K, 5L).
Meibomian Glands Showed Signs of Degeneration
in the Eyelids of Affected Cþ/HMice
Morphologic analyses of upper eyelids of Cþ/Hmice aged 3M
to 9M (Figs. 7C–L) revealed degeneration of Meibomian glands
characterized by the absence of lobular cells (Fig. 7, crosses)
and the appearance of cysts (Fig. 7, asterisks). Eyelids of wild-
type littermates from the same age group showed fully
developed lobular cells and did not develop cysts (Fig. 7A).
Staining with Sudan III to detect lipid content of Meibomian
glands suggested an absence of lipid-filled globular cells in
eyelids of Cþ/H– mice as early as 3 months of age (Fig. 7D), as
well as in older mice (Figs. 7F, 7H, 7J, 7L). Wild-type littermates
displayed normal lipid content (Fig. 7B).
FIGURE 2. Microscopic appearance of the skin phenotype in Cþ/H
and wild-type mice. A slightly thickened epidermis (crosses) could be
observed as early as P7 in Cþ/H mice (B) compared to unaffected
littermates (A). Sebaceous glands (arrows) started to degenerate at
approximately P28 (D), while unaffected animals showed fully
functional sebaceous glands during the entire observed time frame
(C, E, G, I). Sebaceous glands were almost completely lost at 2 months
of age (F) and absent from 3 months onwards (H, J) in Cþ/H mice.
Hair follicles were still present in the skin of affected mice until 2
months of age (B, D, F, asterisks) but were completely lost at 3 months
(H, J). Scale bars: 50 lm.
FIGURE 3. Macroscopic appearance of the corneal phenotype in older
mice. Corneal opacities were observed starting at approximately 6
months of age in half of all affected mice. The corneal tissue did not
show a macroscopic increase at this stage and the surface of the cornea
appeared to remain smooth. (A, 7 months) Starting at the center of the
cornea, an increase of tissue began forming a few weeks afterwards.
This increase of cloudy tissue expanded both in width and depth (B, 8
months) and was infiltrated by blood vessels (C, 10 months). Tissue
increase appeared to continue over the entire life span of the animals
until eyelid closure was severely impaired (D, 12 months).
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The Cþ/H– Mutation Is Predicted to Cause
Reorientation of Helix a12 and Disruption of
Contacts Between Helices a12 and a1 in the
Gasdermin A3 Protein
Insertion of one nucleotide in exon 11 of the Gsdma3 gene
(c.1280_1281insC, Fig. 8A) was predicted to cause a frame
shift affecting the C-terminal 30 amino acids of the protein,
thus leading to truncation of the last nine amino acids by a
premature stop codon (Fig. 8B). Interestingly, this frame shift
was predicted to lead to amino acid exchanges of aspartate 433
(p.Asp433Arg) and histidine 436 (p.His436Pro), two amino
acids (Fig. 8B, open arrowheads) that have been described to
directly interact with the N-terminal domain of Gasdermin
A3.21
The frame shift is further predicted to incorporate eight
helix-breaking prolines that likely prevent the formation of
helix a12.
DISCUSSION
We describe a mouse model affected by a novel Gsdma3
mutation that shows skin and sebaceous gland, as well as
corneal and Meibomian gland phenotypes.
Gasdermin A3 is relevant to the process of pyroptotic cell
death.22,26 The C-terminal domain of Gasdermin A3 auto-
inhibits its N-terminal domain.26 Cleavage of the protein by its
unknown activator leads to dissociation of the two domains,
which activates the N-terminal portion of the protein.
Activated N-termini migrate to the cell membrane and form
pore-like multimers of 16 subunits that incorporate into the
membrane and allow for discharge of cellular contents,
resulting in pyroptotic cell death.26 In wild type, a similar
mechanism is observed in sebaceous glands of the skin and in
the Meibomian glands of the eyelids where sebocytes undergo
controlled cell-death, releasing their contents as sebum, which
is secreted by these two glands.27,28 In this context, Runkel et
al.8 has also speculated on a possible role of Gsdma3 in the
differentiation of progenitor cells into sebocytes. While the
molecular process underlying controlled sebocyte death is
different from pyroptosis29 and possibly independent from
Gasdermin A3, a dysfunction in Gasdermin A3 autoinhibition
would lead to a premature discharge of cellular contents from
basal cells of Meibomian glands, which later differentiate into
sebocytes.8
Cþ/H mice display both degeneration of the sebaceous
glands in the skin and abnormal morphology of Meibomian
glands, including loss of sebum-filled lobular cells and the
appearance of large cysts in the eyelids.
Absence of lobular cells prevents the secretion of sebum
from these glands onto the eye. This leads to a change in the
composition of the tear-film, depriving it of lipid compo-
nents13,14 and influencing both its evaporation (which is
fastened) and refractive index. Rapid evaporation of the
protective tear-film then leads to dehydration of the cornea
and severely reduced resistance to mechanical irritation, as
well as bacterial or viral infection.13,30 The reduction or loss of
the protective tear-film likely is the cause for the corneal
aberrations described in this report and in several other
Gsdma3 mutant mouse lines.1,2,8
Eyelids of affected Cþ/H mice display degenerated
Meibomian glands with reduced lipid content as early as age
3 months, the earliest time point at which a corneal phenotype
could be observed in these mice. This suggests a correlation
between Meibomian gland degeneration and the observed
inflammatory reaction of the cornea. To further evaluate the
link between these two phenotypes, a detailed examination of
the molecular mechanisms in the eyelids of Cþ/H animals is
required at different time points.
Interestingly, dysfunction of Meibomian glands and the
resulting changes in tear-film composition are also a prominent
feature of EDE, one of the most prevalent diseases of the
human eye.13 While, in most cases, EDE is initially caused by an
obstruction of Meibomian gland ducts by foreign material or
tissue, a cystic degeneration of the Meibomian glands can be
observed in later stages of untreated EDE.11,31 Similarly, we and
others observed cystic degeneration in the eyelids of Cþ/H
and other Gsdma3 mutant mice.3
Similar as observed in late stage EDE patients, Cþ/H mice
display an inflammatory response of the cornea along with
signs of neovascularization and possible angiogenesis.32–36 This
mouse model might serve as a useful animal model for EDE and
FIGURE 4. Microscopic appearance of the cornea in younger mice.
During the first 3 months of life, corneal morphology of affected mice
(B, D, F, H) showed no apparent differences to wild-type corneas (A, C,
E, G, I). From 4 months onwards, corneas of affected mice seemed to
show signs of neovascularization (J, white arrows). Black arrows point
toward the basal epithelial layer. Scale bars: 50 lm.
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would allow us to study the molecular and morphologic causes
as well as the progression of Meibomian gland degeneration in
vivo. A more in-depth description of the corneal phenotype
including immunohistochemical and gene expression analyses
of known molecular factors in corneal inflammation and
neovascularization36–41 (for review see Ref. 42) might help to
establish the pathway of inflammatory response and vasculo-
genesis in these mice. This report provides an initial
description of this new mouse line and hints at its possible
use in EDE research.
The Cþ/H mouse line further allows us to study the
correlation between structural elements of the Gasdermin A3
protein and the phenotypes observed in Gsdma3 mutant mice:
on the molecular level, mutations in the C-terminal region of
Gasdermin A3 were described to prevent efficient auto-
inhibition and lead to unregulated pyroptosis in cells
expressing Gasdermin A322,26 including basal cells of the
Meibomian glands.8 In mice, this manifests phenotypically in
complete hair-loss within the first 3 months of life due to
degeneration of sebaceous glands in the skin of affected
animals and the subsequent disruption of the natural hair-
cycle.18
While the hair-loss phenotype can be observed in all known
Gsdma3 mutations, including Cþ/H, the corneal phenotype
is not consistently reported in these animals. The late onset of
the corneal phenotype and its irregular occurrence support
the hypothesis that it is a secondary effect caused by the
degeneration of Meibomian glands. For a primary effect of the
mutation, we would expect this phenotype to occur bilaterally
in all animals carrying the mutation. Additionally, two Gsdma3
mouse lines with functional Meibomian glands have been
observed (Rco28 and RIKEN00745/þ3) and lack the corneal
phenotype.
However, a clear correlation between the predicted severity
of a mutation and presence of functional Meibomian glands in
affected animals seems difficult. Based on SIFT scoring (in the
public domain, http://sift.jcvi.org/), an online tool to predict
the severity of mutations, two Gsdma3 mutations, Rco2
(p.Leu343Pro) and RIKEN00745/þ (p.Tyr442*), incorporate
amino acid changes that are predicted to severely influence
protein structure and function (with a SIFT score of 0.00) but
show intact Meibomian glands in combination with a severe
skin phenotype.3,8 While the RIKEN00745/þ p.Tyr442* muta-
tion3 only affects the last few amino acids of the C-terminus,
the Rco2 p.Leu343Pro mutation8 is located in a highly
conserved stretch of amino acids in helix a8 where any kind
of change is predicted to disrupt protein structure according to
SIFT scoring. The exchange of leucine to proline should
effectively break helix a8 in this mutation. Despite these
putatively disruptive changes, Meibomian glands remain
functional in Rco2 (age: 2 months8) and RIKEN00745/þ (age:
10 months3) mice while sebaceous glands are absent from the
skin of these animals. In contrast, three other Gsdma3
mutations (Ae, Bsk, and M2Btlr) show changes in the adjacent
tyrosine residue (Ae: p.Tyr344His,4 Bsk,5 and M2Btlr:
p.Tyr344Cys). These amino acid changes are predicted to only
mildly influence protein structure (SIFT scores are 0.13 and
0.18, respectively), yet these mice show a corneal phenotype.
Meibomian gland morphology was not described for these
three mouse lines. However, tyrosine 344 is predicted to
directly contact amino acids located in the N-terminal domain
of Gasdermin A3,21 which could explain the high impact of
FIGURE 5. Morphologic changes of the cornea in Cþ/H mice. Thickening of the stromal layer (crosses) of the cornea was observed at
approximately 6 months of age in half of the affected mice, accompanied by increasing signs of neovascularization (C, G, K, pluses). Some of these
newly formed vessels can be identified as blood vessels by the presence of clotted blood cells (C, G, K, asterisks). From 12 months onwards, the
epithelial layer (double crosses) began to thicken and became disorganized (G, K). In very old mice (17 months, K, L) formation of an extra layer
above the epithelium was observed, possibly consisting of dead epithelial cells. In comparison, corneas of unaffected littermates showed a normal,
wild type morphology even at very old ages (A, B, E, F, I, J). Scale bars: 200 lm in overviews and 50 lm in magnifications.
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FIGURE 6. Immunohistochemical analyses of affected and unaffected corneas of 3M- and 6M-old mice. Corneas of wild type (A–D, M–P) and
heterozygous Cþ/H mice that do not display a macroscopic corneal phenotype (E–H, Q–T) showed normal morphology with laminin-positive
(magenta) blood vessels present only in the epithelial layer (arrowheads) and a distinct, double layered Descemet’s membrane stained by anti-
laminin (arrows). In unaffected heterozygous Cþ/H animals, the laminin staining showed a fragmented immunoreactivity pattern at the
Descemet’s membrane (G, S, arrows). No CD3þT-cells (green) were detected in the corneas of these animals (B, F, N, R). Cþ/Hmice that displayed
a macroscopic corneal phenotype (I–L, U–AB) showed weaker staining of the Descemet’s membrane with anti-laminin (K, W, AA, arrows). Blood
vessels appeared to be missing in the epithelium (W, AA, arrowheads). Putative blood and lymphatic vessels are present in the corneal stroma of
these mice, possibly growing toward the epithelium (AA, AB, asterisks). Scale bars: 50 lm.
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mutations in this particular residue compared to the milder
phenotype observed in leucine 343 mutants.
The mutation described in this publication (p.Gln427Profs*
30) is located in the far C-terminal region of the protein, in a b-
sheet structure preceding a turn directly upstream of the last
helix (a12) of the Gasdermin A3 protein (Fig. 8A). The
exchange of the wild type glutamine for proline at amino acid
position 427 is expected to influence protein structure with a
SIFT score of 0.01, possibly leading to a spatial reorientation of
helix a12.
Furthermore, in the wild type protein, two amino acids
located in helix a12 (Asp433 and His436) engage in direct
contact with the very N-terminal helix a1 (contacting Arg13
and Asp6, respectively). These amino acids are changed to
Arg433 and Pro436 in Cþ/Hmice (Fig. 8B, open arrowheads)
and possibly display an altered spatial orientation due to the
appearance of a proline residue at upstream position 427. This
could potentially disrupt contact between helices a12 and a1.
The wild-type helix a12 is positioned centrally in a barrel-
like structure formed by helices a5&6 and a9&10, which is
flanked by helices a8 and a11 (Fig. 8A). The finding that the
frame shift Cþ/H mutation likely disrupts this structural
element suggested that a12s central position in the barrel
might be important for the integrity of the C-terminal domain.
Mutations in helix a12 could therefore indirectly affect the
positions of amino acids Ile359, Leu409, and Ala412 located in
the two helices a9 and a11, possibly disrupting their ability to
contact their N-terminal partners in helix a4.21
Additionally, the Cþ/Hmutation described herein causes a
frame shift that severely alters the amino acid composition of
the C-terminus and truncates the protein by nine amino acids.
Due to the appearance of eight helix-breaking proline residues
in the mutated C-terminus (Fig. 8B, asterisks), it is highly
unlikely that this region will form a helix and can sustain the
wild-type structure of the C-terminal domain.
RIKEN00745/þ (p.Tyr442*) is the only other known
Gsdma3 mutation located in or near helix a12.3 Interestingly,
this mutation is neither described to result in a corneal
phenotype nor in a degeneration of Meibomian glands.3 This
could suggest that truncation of helix a12 (as observed in
RIKEN00745/þ) impacts protein structure and function less
severely than its spatial relocation or disruption of its helical
structure (as predicted for the Cþ/Hmutation). Furthermore,
the RIKEN00745/þ mutation does not affect Asp433 and
His436, hence contact between helices a12 and a1 should still
be possible. We speculate that this might be the reason for the
missing corneal and Meibomian phenotypes in this mouse
model.
It remains unclear whether positioning and secondary
structure of helix a12 have any impact on protein function or if
the severe phenotype of Cþ/H mice solely stems from the
disrupted contact between helices a12 and a1 due to the
amino acid changes at positions 433 and 436.
While the appearance of functional Meibomian glands in
Rco2 and RIKEN00745/þ suggests that the integrity of these
contact points is paramount for Meibomian gland function, it
will be a matter of further experiments to test this hypothesis.
It is highly interesting that mutations in different regions of the
Gasdermin A3 protein (and even mutations in two adjacent
amino acid residues) can lead to such opposing Meibomian
gland phenotypes.
To summarize, we described a novel mouse line, Cþ/H,
carrying a C-terminal mutation in Gsdma3, which displays skin
and corneal phenotypes. Due to a degeneration of Meibomian
glands, this mouse line could serve as an animal model for late
stage EDE, one of the most prevalent diseases of the human
eye.
FIGURE 7. Morphology and lipid-stain in upper eyelids of Cþ/Hmice and controls. Upper eyelids of wild-type mice displayed distinct populations
of differentiated lobular cells that stain positive for lipid content (A, B, double crosses, dark red signals in B: Sudan III staining). Abnormal cysts
were not observed in wild-type mice (A, B). Affected littermates (C–L) from the same age group displayed aggregates of degenerated lobular cells
(crosses) that did not or weakly stain positive for lipids (dark red signals in D, F, H, J, L: Sudan III staining). Cysts of up to 50 lm in diameter were
only detected in the eyelids of affected animals (asterisks). Consecutive slices were used for HE and Sudan III staining. Scale bars: 50 lm.
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